Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment80% Female49%% WhiteN/A
Product ClassAnticonvulsantsSponsor Protocol NumberYTCEData PartnerJohnson & JohnsonCondition StudiedEpilepsyMean/Median Age (Years)27
Supporting Documentation
- Clinical Study Report Available
Additional Information
Please note: individual participant-level data are not available for this trial. Only the clinical study report is available.